This trial is testing a new way to map out cancer radiation treatment plans that could reduce risk or severity of radiation pneumonitis.
1 Primary · 1 Secondary · Reporting Duration: One year.
Awards & Highlights
2 Treatment Groups
Standard-of-care Radiation Therapy for lung cancer using HXe MRI for diagnosis.
1 of 2
Guided Radiation Therapy for lung cancer using HXe MRI for functional lung avoid...
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Hyperpolarized xenon MRI · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18 - 85 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are participants still welcome to join this clinical investigation?
"Correct. Records on clinicaltrials.gov attest to the fact that this medical trial, which was first posted on March 17th 2022, is actively seeking participants. To date, 20 individuals are required from a single site." - Anonymous Online Contributor
What is the ideal demographic of individuals to be involved in this research?
"This trial is seeking 20 individuals with non-small cell lung carcinoma between 18 and 85. The primary criteria for eligibility include having a diagnosis of non-small cell lung cancer, planning to receive radiation therapy, or being diagnosed with de novo lung cancer while also exhibiting natural co morbidities such as COPD stage 3+. It is preferred that participants have had successful radiation treatment in the past for a prior case of lung cancer." - Anonymous Online Contributor
Has the FDA approved Hyperpolarized xenon MRI for medical use?
"The safety of Hyperpolarized xenon MRI is assessed as a 1 on the scale, given that this is an initial Phase 1 trial with scant data available to evaluate its efficacy and security." - Anonymous Online Contributor
How many participants are involved in the current research endeavor?
"Yes, the information on clinicaltrials.gov attests that this medical trial is currently recruiting patients. This research was first posted on March 17th 2022 and has since been modified as of March 29th 2022. The study requires 20 individuals to be recruited from one centre." - Anonymous Online Contributor
Is eligibility for this experiment restricted to those under 45 years of age?
"According to the eligibility criteria for this trial, participants must fall between 18 and 85 years old. The medical landscape is vast with 21 clinical trials available specifically targeting those under 18 and 1360 trails open to patients above 65." - Anonymous Online Contributor